EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark MultiVAX was filed as Word mark on 03/30/2010 at the European Union Intellectual Property Office.
It was registered as a trademark on 02/16/2011.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 008993032 |
| Application date | March 30, 2010 |
| Publication date | May 10, 2010 |
| Entry date | February 16, 2011 |
| Expiration date | March 30, 2030 |
Trademark owner
Trademark representatives
Grünstraße 1
75172 Pforzheim
DE
Objection / Complaint
goods and services
1
Chemicals, biochemicals and reagents used in scientific or medical research and industry, namely preparations of naturally occurring or synthetic substances for use in making vaccines, including, but not limited to lipids such as lipopolysaccharides (LPS), that are known to, thought to or intended to be used to stimulate or modulate cells of the immune system, including but not limited to dendritic cells via cellular pattern recognition receptors including, but not limited to Toll-like receptor (TLR)
5
Pharmaceutical preparations, for medical and diagnostic purposes, namely preparations of naturally occurring or synthetic substances as adjuvants for use with vaccines, including, but not limited to lipids such as lipopolysaccharides (LPS), that are known to, though to or intended to be used to stimulate or modulate cells of the immune system, including but not limited to dendritic cells via cellular pattern recognition receptors including, but not limited to Toll-like receptor (TLR), excluding veterinary preparations
42
Biological research, clinical research and medical research, namely research and development of vaccines and medicines with regards of preparations of naturally occurring or synthetic substances, including, but not limited to lipids such as lipopolysaccharides (LPS), that are known to, thought to or intended to be used to stimulate or modulate cells of the immune system, including but not limited to dendritic cells via cellular pattern recognition receptors including, but not limited to Toll-like receptor (TLR)
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| December 10, 2020 | Change Representative, Published | ||
| February 12, 2020 | Extension, Trade mark renewed |
ID: 11008993032